(Utkast) Kommisjonsforordning (EU) .../... om endring av vedlegget til forordning (EU) nr. 231/2012 om fastsettelse av spesifikasjoner for tilsetningsstoffer i næringsmidler oppført i vedlegg II og III til europaparlaments- og rådsforordning (EF) nr. 1333/2008, med hensyn til spesifikasjoner for enzymatisk framstilt steviolglykosider for å inkludere rebaudiosid M framstilt via enzymatisk omdanning av høyrenset rebaudiosid A steviabladekstrakt (E 960c(ii)) ved bruk av den genmodifiserte gjæren K. phaffii CGMCC 7539
Tilsetningsstoffer i næringsmidler: endringsbestemmelser om rebaudiosid
Utkast til kommisjonsforordning sendt til Europaparlamentet og Rådet for klarering og publisert i EUs komitologiregister 13.8.2026
Bakgrunn
(fra kommisjonsforordningen)
(1) Commission Regulation (EU) No 231/2012 lays down specifications for food additives listed in Annexes II and III to Regulation (EC) No 1333/2008.
(2) The specifications for food additives may be updated in accordance with the common procedure referred to in Article 3(1) of Regulation (EC) No 1331/2008, either on the initiative of the Commission or following an application from a Member State or an interested party.
(3) The currently authorised food additive ‘enzymatically produced steviol glycosides’ (E 960c) is included in the group ‘steviol glycosides (E960a-E960c)’ in Part C of Annex II to Regulation (EC) No 1333/2008.
(4) Regulation (EU) No 231/2012 provides that ‘rebaudioside M produced via enzymatic conversion of highly purified rebaudioside A stevia leaf extracts’ (E 960c(ii)) is produced using UDP-glucosyltransferase and sucrose synthase enzymes produced by the genetically modified strains of E. coli (pPM294, pFAF170 and pSK401).
(5) On 22 December 2022, an application was submitted to the Commission for the amendment of the specifications to include in the specifications for rebaudioside M produced via enzyme modification of steviol glycosides from stevia (E 960c(i)) rebaudioside M produced via enzyme-catalysed bioconversion using the genetically modified yeast K. phaffii CGMCC 7539. However, in the course of the risk assessment, the applicant revised its original proposal and requested the amendment of the specifications for rebaudioside M produced via enzymatic conversion of highly purified rebaudioside A stevia leaf extracts (E 960c(ii)) instead. The Commission made the application available to the Member States pursuant to Article 4 of Regulation (EC) No 1331/2008.
(6) In the opinion published on 14 May 2025, the European Food Safety Authority (‘the Authority’) evaluated the safety of the proposed amendment of the specifications for rebaudioside M produced via enzyme-catalysed bioconversion using the genetically modified yeast K. phaffii CGMCC 7539. The Authority concluded that there is no safety concern with respect to the proposed amendment to the specifications of E 960c(i) or E 960c(ii) in the Annex to Regulation (EU) No 231/2012 related to the use of the new genetically modified strain K. phaffii CGMCC 7539 in the manufacturing process of the food additive Rebaudioside M produced via enzyme-catalysed bioconversion. The Authority considered that it is in the remit of the risk managers to decide whether the proposed changes in the specifications should result in an amendment of the already existing specifications of E 960c(i) or E 960c(ii). In addition, the Authority recommended introducing a specific entry for kaurenoic acid in the proposed specifications.
(7) The Annex to Regulation (EU) No 231/2012 should therefore be amended accordingly.
(8) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,